The current concepts of use of ACEI / ARB, SGLT2 inhibitors & Finerenone in CKD |Dr. Ashok Kirpalani

The current concepts of use of ACEI / ARB, SGLT2 inhibitors & Finerenone in CKD |Dr. Ashok KirpalaniSee more

The current concepts of use of ACEI / ARB, SGLT2 inhibitors & Finerenone in CKD |Dr. Ashok Kirpalani

ACE inhibitors and ARBS in Advanced CKD (The STOP ACE trial)See more

ACE inhibitors and ARBS in Advanced CKD (The STOP ACE trial)

DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit LambaSee more

DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit Lamba

SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?See more

SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?

ACEI/ARB Use in Proteinuric Chronic Kidney DiseaseSee more

ACEI/ARB Use in Proteinuric Chronic Kidney Disease

Role of SGLT2 Inhibitors in CKDSee more

Role of SGLT2 Inhibitors in CKD

How SGLT2 Inhibitors Protect The KidneySee more

How SGLT2 Inhibitors Protect The Kidney

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKDSee more

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney DiseaseSee more

George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21See more

CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21

Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor TrialsSee more

Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials

How do ACE inhibitors work?See more

How do ACE inhibitors work?

HPS Pharmacies Lecture Series Webinar (#17): Update on antihypertensivesSee more

HPS Pharmacies Lecture Series Webinar (#17): Update on antihypertensives

Finerenone: Evaluating and Understanding this Drug as TreatmentSee more

Finerenone: Evaluating and Understanding this Drug as Treatment

Historic Evolution of Mineralocorticoid Receptors CV and Renal Protection Muthiah Vaduganathan,See more

Historic Evolution of Mineralocorticoid Receptors CV and Renal Protection Muthiah Vaduganathan,

SGLT2 Inhibitors in Chronic Kidney DiseaseSee more

SGLT2 Inhibitors in Chronic Kidney Disease

Effects of canagliflozin versus finerenone on cardiorenal outcomesSee more

Effects of canagliflozin versus finerenone on cardiorenal outcomes

Neph for PCPs: ACEi or ARB in advanced CKDSee more

Neph for PCPs: ACEi or ARB in advanced CKD

Field Notes Ep. 19 | Slowing Down Progression of CKD - SGLT2 Inhibitors with Dr. Robert KossmannSee more

Field Notes Ep. 19 | Slowing Down Progression of CKD - SGLT2 Inhibitors with Dr. Robert Kossmann

Events